JEMS Development Editor Mike Brown welcomes Joe Landolina, co-founder and CEO of Cresilon, alongside Sean Allen, Director of Education for TRAUMAGEL, to dive into a breakthrough in hemorrhage control technology. TRAUMAGEL, a plant-based, easy-to-use hemostatic gel, stops moderate to severe external bleeding within seconds without the need for finger packing or complex dressings. Developed over 15 years and backed by a successful animal health platform, this innovative product adapts dynamically to wounds—crucial for moving patients—and supports natural clot formation without disrupting it. Sean shares firsthand insights on field use and training, highlighting TRAUMAGEL’s potential to reduce tourniquet necessity and simplify emergency care. The team also explores real-world applications, including rural trauma cases and gunshot wounds, emphasizing this gel’s transformative impact on prehospital hemorrhage management.